Pune, India, June, 2018 /press release/- Market Research Future Published a Half Cooked Research Report on Global Crack Tooth Syndrome Market Research Report.
Cracked tooth syndrome (CTS) also called as cracked cusp syndrome, split tooth syndrome or incomplete fracture of posterior teeth is a dental condition characterized by a fractured but unbroken tooth. The global CTS market is valued at USD 3.5 billion in 2016, which is expected to reach to USD 4.96 billion in 2023 at a CAGR of 6.0 %.
Rise In Risk Factors Is The Prime Reason For Market Growth
The demographic drivers of the global CTS market are increasing geriatric population, growing awareness, and rise in risk factors generating demand such as consumption of fat and sugar-rich foods and others. According to estimates of American Dental Association, estimated 52.3% of adults visited the dentist every six months, and 15.4% per year, in 2015. Thus, a large market for CTS is easily comprehended. The growing risk factors and cause of CTS such as previous dental restorative procedures, occlusal factors, anatomical considerations, trauma, and others are driving a significant demand. About 37.9 % people had at least one cracked tooth in their lifetime, with the first permanent molars being the most commonly affected.
Technological Drivers And Advancements In Dentistry Are Other Drivers Of The Market
Technical drivers of the market are the development of biocompatible and bioabsorbable materials with better osteointegration properties, development of silicon dental adhesives, CAD/CAM technology, and others. Aesthetically better materials resembling natural teeth has generated more significant demand for cosmetic dentistry.
High Cost Of Treatment Coupled With High Failure Rates Are Constraints On The Market
The high cost of treating dental implants, coupled with poor reimbursements reflected by high out-of-pocket costs is hampering the market. The FDI World Dental Federation estimates out-of-pocket costs approximately at 55 % of total dental care spending, with comparative figures for general health care amounting to just 20 %. CTS has very variable symptoms and is notoriously difficult to diagnose. Endodontic treatment of cracked teeth has a relatively high failure rate of 14.5 % over a two years period, which is another restraint of the market.
To generate a bird’s view of the global CTS market, the report is segmented based on diagnosis, types, drug class, treatment, devices, and regions.
Based on the diagnosis, the market is segmented into the clinical examination, dye test, X-ray, transillumination, radiograph, and others.
Based on types, the market is segmented into entirely fractured teeth and incompletely fractured. The completely fractured teeth segment is further segregated into obliquely directed and vertically directed. The incompletely fractured teeth segment is further separated into oblique and vertical.
Based on drug class, this market is segmented into painkillers, anti-biotic, and others.
Based on treatment, this market is segmented into stabilization, crown restoration, root canal therapy, extraction, and others.
Based on devices, this market is segmented into implants, adhesives, expendables, and others.
Based on the regions, the market has been segmented as North America, Europe, Asia Pacific Middle East and Africa and rest of the world.
North America led by the U.S. accounts for the most significant market share of the global CTS treatment market followed by Europe. The European market expected to be driven by Germany owing to its sizeable medical device industry.
However, these markets are stagnant, and there is a definite shift towards the Asia Pacific regions led by India and China. The Asia Pacific will be the fastest growing market, and the growth will be driven by China, and India as these nations have the huge population and the low cost of CTS treatment. The Middle East and Africa are expected to generate moderate growth owing to poor socio-economic conditions in the African continent.
Some of the dominant vendors operating in the report are Institut Straumann AG, Henry Schein, Inc., Zimmer Biomet, Ivoclar Vivadent AG, 3M, Nobel Biocare, Osstem Prosthetics, DENTSPLY Sirona, CAMLOG Biotechnologies AG Planmeca OY, and others.